-
1by Matthias Gromeier, Darell D Bigner, Smita K Nair, Karenia Landa, Sin-Ho Jung, Georgia M Beasley, Norma E Farrow, Maria Angelica Selim, Carol Ann Wiggs, Andrea True Kelly, April KS Salama“...) antagonists have improved the prognosis for many patients with melanoma, around 60% fail therapy. PVSRIPO is a...”
Published 2021-04-01
Get full text
Article -
2
-
3by Brown, Michael Clavon“...<p>Our group has pioneered the development of a live-attenuated poliovirus, called PVSRIPO...”
Published 2016
Get full text
-
4by Mubeen M. Mosaheb, Elena Y. Dobrikova, Michael C. Brown, Yuanfan Yang, Jana Cable, Hideho Okada, Smita K. Nair, Darell D. Bigner, David M. Ashley, Matthias Gromeier“...Experimental PVSRIPO oncolytic virus therapy of glioblastoma has shown long-term efficacy in a...”
Published 2020-01-01
Get full text
Article -
5“... (PVSRIPO) had an overall survival of 21% vs. 14% for the control group at 24 months, and 21% vs. 4% at 36...”
Get full text
Article -
6“... trials with the recombinant adenovirus DNX-2401 (Ad5-delta24-RGD), polio-rhinovirus chimera (PVSRIPO...”
Get full text
Article